Resident Research

In addition to being dedicated to the training of pediatric residents, the faculty at Cardinal Glennon Children's Hospital is also at the forefront of basic science and clinical research. Over the past several years, there has been increasing resident involvement in the research process.

Residents are required participate in a Quality Assurance- Quality Improvement project that spans their residency. A timeline helps guide them through Institutional Review Board (IRB) certification, mentor selection, background/ reference review, project implementation and final presentation. Several times during the project, the resident meets with an expert from the Saint Louis University School of Public Health to optimize their research focus, develop a sound strategy for data collection, and then finally for data analysis, statistical representation and presentation to the Department.

FACULTY AND RESIDENT PUBLICATIONS, ABSTRACTS AND PRESENTATIONS

In the past five years, pediatric residents/fellows and faculty have had over 300 publications including chapters in books, abstracts and articles in critically acclaimed journals. These publications cover all areas of clinical medicine and basic science relating to pediatrics and related areas of medicine.

RESEARCH BEYOND QA/QI

At the present time, interested residents and fellows are engaged in several clinical and/or basic science research projects which are being supervised by faculty mentors. Many of these will result in publication in critically acclaimed journals or presentation at national or international conferences. More importantly, past and present projects have contributed greatly to the care of children.

GRANT AWARDS

During the present academic year, numerous funding agencies and local and national organizations supported the research activities of members of the Department of Pediatrics. Active grants for the Department of Pediatrics total more than $3 million at present.   Major sources of funds included the National Institutes of Health, the Cystic Fibrosis Foundation, the American Heart Association, the American Diabetes Association, Alpha-1 Antitrypsin society, and private industry.

---